Skip to content
DraconiticResearch
Search Sources API
182,549 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY-NCJournal of pain research

Intrathecal EP4 Antagonist Alleviates Neuronal and Glial Activation and Hyperalgesia in a Mouse Model of Endometriosis.

  • Peiya Fan1,2,3
  • Wei Xiong4
  • Yixiao Chen1,2
  • Yunjing Bai1,2
  • Tian Li1,2
4 affiliations
  1. 1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  2. 2Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumor Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  3. 3Department of Anesthesiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, People's Republic of China.
  4. 4Department of Neurology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Read full textPDFDOICite

Abstract

Purpose

Endometriosis-associated pain presents a significant clinical challenge due to its complex nature, often manifesting as mixed pain types and hyperalgesia, with current treatments offering limited relief. Previous studies have mostly focused on the mechanisms of peripheral lesions in endometriosis, while research on the regulatory role of the central nervous system in the development and progression of endometriosis-associated chronic pain remains scarce. This study explores the therapeutic potential of an EP4 antagonist (E7046) in a mouse model of endometriosis-induced hyperalgesia.Methods

Daily intrathecal administration of E7046 was performed, and pain thresholds were measured at various intervals. Neuronal and glial activation in the spinal cord were assessed using immunofluorescence and Nissl staining techniques.Results

EP4 antagonist (E7046) treatment reduced hyperalgesia and lowered pro-inflammatory cytokine levels by 30-40% relative to saline-treated endometriosis mice (n = 4 per group). Further, a reduction in neuronal and glial cell activation in the spinal cord was observed, suggesting decreased spinal inflammation and neuronal sensitization.Discussion

These findings indicate that the EP4 antagonist effectively mitigates endometriosis-induced hyperalgesia by inhibiting neural and glial activation. E7046 may confer beneficial effects against endometriosis-related pain in this preclinical animal model, and further mechanistic and translational studies are still needed.

Related

  1. Hepatic Nnmt Deficiency Alleviates Thiamethoxam-Induced Hepatic Steatosis Via AMPK Activation
    Yilian Liu, Zixuan Meng, Siting Fan +2
    PhenomicsPeer-reviewedLicence not statedFull textPharmacology & toxicologyPMC
  2. Amphibian‐Derived Peptide OA‐AL14 Alleviates UVB‐Induced Skin Photoaging via Autophagy Activation Mediated by the AMPK/mTOR Pathway
    Ying Peng, Yu Wu, Zhe Fu +14
    Integrative ZoologyPeer-reviewedCC BY-NC-ND25 citedGeneral medicineOpenAlex
  3. CD200/CD200R1 activation alleviates central sensitization in chronic migraine via STAT6
    ZiChao Li, Dan Li, ZhenZhen Fan +2
    Molecular PainPeer-reviewedCC BY-NC 4.0Full textPsychiatry & mental healthPMC
  4. BMI1 Overexpression Alleviates Metabolic Syndrome‐Related Liver Injury by Inhibiting the Activation of the METTL3/AHNAK Axis
    Yun‐Jiang Chen, Bei Song, Kai‐Yu Cai +2
    The Kaohsiung Journal of Medical SciencesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC
  5. Dioscin Alleviates Diabetic Kidney Disease via Activation of the Nrf2/HO-1 Signaling Axis.
    Yan Li, Xiaoyun Zhang, Mansheng Zhang +3
    Diabetes, metabolic syndrome and obesity : targets and therapyPeer-reviewedCC BY-NCFull textEndocrinology & metabolismEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{fan2026intrathecal,
  title = {{Intrathecal EP4 Antagonist Alleviates Neuronal and Glial Activation and Hyperalgesia in a Mouse Model of Endometriosis.}},
  author = {Peiya Fan and Wei Xiong and Yixiao Chen and Yunjing Bai and Tian Li},
  journal = {Journal of pain research},
  year = {2026},
  month = oct,
  doi = {10.2147/jpr.s638159},
  url = {https://europepmc.org/article/MED/42948656},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Intrathecal EP4 Antagonist Alleviates Neuronal and Glial Activation and Hyperalgesia in a Mouse Model of Endometriosis.
AU  - Peiya Fan
AU  - Wei Xiong
AU  - Yixiao Chen
AU  - Yunjing Bai
AU  - Tian Li
PY  - 2026
DA  - 2026/10/23
JO  - Journal of pain research
DO  - 10.2147/jpr.s638159
UR  - https://europepmc.org/article/MED/42948656
AB  - Purpose  Endometriosis-associated pain presents a significant clinical challenge due to its complex nature, often manifesting as mixed pain types and hyperalgesia, with current treatments offering limited relief. Previous studies have mostly focused on the mechanisms of peripheral lesions in endometriosis, while research on the regulatory role of the central nervous system in the development and progression of endometriosis-associated chronic pain remains scarce. This study explores the therapeutic potential of an EP4 antagonist (E7046) in a mouse model of endometriosis-induced hyperalgesia.Methods  Daily intrathecal administration of E7046 was performed, and pain thresholds were measured at various intervals. Neuronal and glial activation in the spinal cord were assessed using immunofluorescence and Nissl staining techniques.Results  EP4 antagonist (E7046) treatment reduced hyperalgesia and lowered pro-inflammatory cytokine levels by 30-40% relative to saline-treated endometriosis mice (n = 4 per group). Further, a reduction in neuronal and glial cell activation in the spinal cord was observed, suggesting decreased spinal inflammation and neuronal sensitization.Discussion  These findings indicate that the EP4 antagonist effectively mitigates endometriosis-induced hyperalgesia by inhibiting neural and glial activation. E7046 may confer beneficial effects against endometriosis-related pain in this preclinical animal model, and further mechanistic and translational studies are still needed.
SN  - 1178-7090
ER  -